Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications, a study shows, making the Type 2 diabetes medication the first shown to lengthen diabetics' lives.
Sep 17, 2015
0
12
A medical journal raised concerns Wednesday about a blood-thinning drug widely used by people at risk of stroke, accusing its manufacturer of concealing safety data and regulators of laxness.
Jul 23, 2014
0
0
(HealthDay)—Twenty-four weeks of empagliflozin + metformin correlates with a significantly greater reduction in hemoglobin A1c (HbA1c) compared with once-daily empagliflozin or twice-daily metformin, according to a study ...
Aug 16, 2016
0
3
For the first time, there's evidence that a diabetes medication, Jardiance, reduces risk of the complications that are the top killer of diabetics: heart attacks, strokes and other cardiovascular damage.
Aug 20, 2015
0
11
A new drug drives down the likelihood that diabetic patients with established cardiovascular disease will suffer or die of heart attack, stroke or heart failure, a new study finds.
Sep 18, 2015
0
13
Researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, presented new evidence that drugs originally developed to treat type 2 diabetes may benefit a wide range of patients ...
Aug 29, 2022
0
7
(HealthDay)—For patients with type 2 diabetes at high cardiovascular risk, empagliflozin is associated with a reduction in incident or worsening nephropathy, according to a study published online June 14 in the New England ...
Jun 15, 2016
0
0
Severe visual illnesses are increasing in our society, and effective treatments are missing for diseases as age-related macular degeneration, diabetic retinopathy, and glaucoma. Both industry and academia are highly interested ...
Jan 27, 2022
0
2
A less-expensive version of the world's top-selling insulin, Sanofi's Lantus, could go on sale in the U.S. late next year.
Sep 28, 2015
0
3
An important line of defense in the fight against the new corona virus SARS-CoV-2 is the formation of neutralizing antibodies. These can eliminate the intruders and have great potential to be used for prevention and treatment ...
Jul 8, 2020
0
2
